These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31832665)

  • 1. Benchmarking as a quality of care improvement tool for patients with ST-elevation myocardial infarction: an NCDR ACTION Registry experience in Latin America.
    Caixeta A; Franken M; Katz M; Lemos PA; Gomes I; Yokota PK; V Alliegro P; Pesaro EE; Neto MC; Valentine CM; Brindis RG; Makdisse M
    Int J Qual Health Care; 2020 Apr; 32(1):A1-A8. PubMed ID: 31832665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
    Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST).
    Filgueiras Filho NM; Feitosa Filho GS; Solla DJF; Argôlo FC; Guimarães PO; Paiva Filho IM; Carvalho LGM; Teixeira LS; Rios MNO; Câmara SF; Novais VO; Barbosa LS; Ballalai CS; De Lúcia CV; Granger CB; Newby LK; Lopes RD
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29980522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in quality indicators using NCDR® registries: First international experience.
    de Barros E Silva PGM; Ribeiro HB; Lopes RD; Macedo TA; Conejo F; do Amaral Baruzzi AC; Okada MY; Garcia JCT; Rodrigues MJ; Furlan V; Ribeiro EE
    Int J Cardiol; 2018 Sep; 267():13-15. PubMed ID: 29861104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental Prognostic Value of Guideline-Directed Medical Therapy, Transradial Access, and Door-to-Balloon Time on Outcomes in ST-Segment-Elevation Myocardial Infarction.
    Huded CP; Kumar A; Johnson M; Abdallah M; Ballout JA; Kravitz K; Menon V; Gullett TC; Hantz S; Ellis SG; Podolsky SR; Meldon SW; Kralovic DM; Brosovich D; Smith E; Kapadia SR; Khot UN
    Circ Cardiovasc Interv; 2019 Mar; 12(3):e007101. PubMed ID: 30871354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
    Bruggmann C; Iglesias JF; Gex-Fabry M; Fesselet R; Vogt P; Sadeghipour F; Voirol P
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):105-115. PubMed ID: 31300969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of quality performance measures for primary percutaneous coronary intervention: A report from a tertiary referral centre in Switzerland.
    Haas C; Fournier S; Iglesias JF; Trana C; Roguelov C; Locca D; Lauriers N; Muller O; Eeckhout E
    Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):435-442. PubMed ID: 26474842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in process and outcome for ST elevation myocardial infarction in central China from 2011 to 2018.
    Zhang Y; Wang S; Qi D; Wang X; Li M; Zhu Z; Cheng Q; Hu D; Gao C
    Chin Med J (Engl); 2023 Sep; 136(18):2203-2209. PubMed ID: 37545028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
    Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock.
    Kumar A; Huded CP; Zhou L; Krittanawong C; Young LD; Krishnaswamy A; Menon V; Lincoff AM; Ellis SG; Reed GW; Kapadia SR; Khot UN
    Am J Cardiol; 2020 Nov; 134():1-7. PubMed ID: 32933753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines).
    Kadakia MB; Desai NR; Alexander KP; Chen AY; Foody JM; Cannon CP; Wiviott SD; Scirica BM;
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1166-77. PubMed ID: 21087753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Presentation, Quality of Care, Risk Factors and Outcomes in Women with Acute ST-Elevation Myocardial Infarction (STEMI): An Observational Report from Six Middle Eastern Countries.
    Shehab A; AlHabib KF; Bhagavathula AS; Hersi A; Alfaleh H; Alshamiri MQ; Ullah A; Sulaiman K; Almahmeed W; Al Suwaidi J; Alsheikh-Ali AA; Amin H; Al Jarallah M; Salam AM
    Curr Vasc Pharmacol; 2019; 17(4):388-395. PubMed ID: 29542414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention.
    Choi SY; Choi BG; Rha SW; Byun JK; Shim MS; Li H; Mashaly A; Choi CU; Park CG; Seo HS; Oh DJ; Jeong MH;
    Int J Cardiol; 2017 Dec; 249():48-54. PubMed ID: 28867244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST-Elevation Acute Myocardial Infarction in Australia-Temporal Trends in Patient Management and Outcomes 1999-2016.
    Aliprandi-Costa B; Morgan L; Snell LC; D Souza M; Kritharides L; French J; Brieger D; Ranasinghe I
    Heart Lung Circ; 2019 Jul; 28(7):1000-1008. PubMed ID: 30006115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative.
    Faridi KF; Garratt KN; Kennedy KF; Maddox TM; Secemsky EA; Butala NM; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e006275. PubMed ID: 32156164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chronic obstructive pulmonary disease on in-hospital morbidity and mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Șerban RC; Hadadi L; Șuș I; Lakatos EK; Demjen Z; Scridon A
    Int J Cardiol; 2017 Sep; 243():437-442. PubMed ID: 28506549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry.
    Riley RF; Don CW; Aldea GS; Mokadam NA; Probstfield J; Maynard C; Goss JR
    J Am Heart Assoc; 2012 Aug; 1(5):e002733. PubMed ID: 26600570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.